PPA
KPTI icon

Parametric Portfolio Associates’s Karyopharm Therapeutics KPTI Stock Holding History

Parametric Portfolio Associates’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.89M Sell
17,086
-1,415
-8% -$176K ﹤0.01% 2447
2021
Q4 		$1.78M Sell
18,501
-1,041
-5% -$104K ﹤0.01% 2501
2021
Q3 		$1.71M Buy
19,542
+8,044
+70% +$835K ﹤0.01% 2525
2021
Q2 		$1.78M Buy
11,498
+5,624
+96% +$816K ﹤0.01% 2501
2021
Q1 		$927K Buy
5,874
+609
+12% +$128K ﹤0.01% 3201
2020
Q4 		$1.22M Buy
5,265
+2,229
+73% +$517K ﹤0.01% 2943
2020
Q3 		$665K Sell
3,036
-6,604
-69% -$1.62M ﹤0.01% 3125
2020
Q2 		$2.74M Sell
9,640
-914
-9% -$270K ﹤0.01% 2299
2020
Q1 		$3.04M Buy
10,554
+3,794
+56% +$1.05M ﹤0.01% 2108
2019
Q4 		$1.94M Buy
6,760
+5,076
+301% +$1.1M ﹤0.01% 2706
2019
Q3 		$243K Buy
1,684
+257
+18% +$34.8K ﹤0.01% 3632
2019
Q2 		$128K Buy
+1,427
New +$115K ﹤0.01% 3809
2017
Q3 		– Sell
-1,306
Closed -$177K – 4040
2017
Q2 		$177K Sell
1,306
-560
-30% -$82.9K ﹤0.01% 3847
2017
Q1 		$359K Buy
1,866
+519
+39% +$83.3K ﹤0.01% 3364
2016
Q4 		$190K Buy
1,347
+19
+1% +$2.57K ﹤0.01% 3605
2016
Q3 		$194K Buy
+1,328
New +$160K ﹤0.01% 3579
2015
Q3 		– Sell
-753
Closed -$307K – 3305
2015
Q2 		$307K Buy
+753
New +$325K ﹤0.01% 3558
2015
Q1 		– Sell
-747
Closed -$419K – 3973
2014
Q4 		$419K Buy
+747
New +$424K ﹤0.01% 3363

Other funds holding KPTI

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ITP
Iron Triangle Partners Cos Cob, Connecticut $875M AUM 49.85% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Parametric Portfolio Associates's KPTI Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Karyopharm Therapeutics (KPTI) stake by 7.6% in Q1 2022, selling an estimated $176K and leaving 17,086 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Parametric Portfolio Associates first reported a position in KPTI in Q4 2014 and has held it in 18 quarters since. The position peaked at $3.04M in Q1 2020. 140 funds tracked by Wall St. Rank hold KPTI as of Q1 2022.

  • Parametric Portfolio Associates held 17,086 shares of Karyopharm Therapeutics worth $1.89M as of Q1 2022.
  • Parametric Portfolio Associates sold 1,415 Karyopharm Therapeutics shares in Q1 2022, an estimated $176K.
  • Karyopharm Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2447 holding.
  • Parametric Portfolio Associates first reported a position in Karyopharm Therapeutics in Q4 2014 and has held it in 18 quarters since.
  • Parametric Portfolio Associates's Karyopharm Therapeutics position peaked at $3.04M in Q1 2020.
  • 140 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.